KLK3 and anemia (phenotype): As per the guidelines, the performance status, pain improvement, anemia, prostate-specific antigen kinetics, and the markers of bone metabolism (urinary N-telopeptide and bone-specific alkaline phosphatase) have been used as prognostic markers.